These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8787888)

  • 1. Pharmacokinetics of cefetamet in plasma and skin blister fluid.
    Zimmerli W; Sansano S; Wittke B
    Antimicrob Agents Chemother; 1996 Jan; 40(1):102-4. PubMed ID: 8787888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA; Stoeckel K
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of timing of food and fluid volume on cefetamet pivoxil absorption in healthy normal volunteers.
    Tam YK; Kneer J; Dubach UC; Stoeckel K
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1556-9. PubMed ID: 2221865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Bryson HM; Brogden RN
    Drugs; 1993 Apr; 45(4):589-621. PubMed ID: 7684677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
    Barbhaiya RH; Shukla UA; Gleason CR; Shyu WC; Wilber RB; Pittman KA
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1204-9. PubMed ID: 2393282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cefetamet pivoxil (Ro 15-8075) with ascending oral doses in normal healthy volunteers.
    Tam YK; Kneer J; Dubach UC; Stoeckel K
    Antimicrob Agents Chemother; 1989 Jun; 33(6):957-9. PubMed ID: 2764545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with hepatic cirrhosis.
    Hayton WL; Kneer J; Blouin RA; Stoeckel K
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1318-22. PubMed ID: 2386364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of cefetamet pivoxil and cefuroxime axetil into the maxillary sinus mucosa at steady state.
    Stoeckel K; Harell M; Dan M
    Antimicrob Agents Chemother; 1996 Mar; 40(3):780-3. PubMed ID: 8851611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of antacid and ranitidine on the pharmacokinetics of oral cefetamet pivoxil.
    Blouin RA; Kneer J; Ambros RJ; Stoeckel K
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1744-8. PubMed ID: 1981000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil.
    Borin MT; Hughes GS; Spillers CR; Patel RK
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1094-9. PubMed ID: 2393268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and inflammatory fluid penetration of cefpodoxime proxetil in volunteers.
    O'Neill P; Nye K; Douce G; Andrews J; Wise R
    Antimicrob Agents Chemother; 1990 Feb; 34(2):232-4. PubMed ID: 2327771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
    Królicki A
    Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects.
    Blouin RA; Kneer J; Stoeckel K
    Antimicrob Agents Chemother; 1989 Mar; 33(3):291-6. PubMed ID: 2729925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency.
    Kneer J; Tam YK; Blouin RA; Frey FJ; Keller E; Stathakis C; Luginbuehl B; Stoeckel K
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1952-7. PubMed ID: 2610506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of oral cefetamet pivoxil (Ro 15-8075) and intravenous cefetamet (Ro 15-8074) in humans: a review.
    Stoeckel K; Tam YK; Kneer J
    Curr Med Res Opin; 1989; 11(7):432-41. PubMed ID: 2673663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans.
    Koup JR; Dubach UC; Brandt R; Wyss R; Stoeckel K
    Antimicrob Agents Chemother; 1988 Apr; 32(4):573-9. PubMed ID: 3377466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human plasma and skin blister fluid levels of griseofulvin following a single oral dose.
    Schäfer-Korting M; Korting HC; Mutschler E
    Eur J Clin Pharmacol; 1985; 29(1):109-13. PubMed ID: 4054199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefetamet pivoxil in the treatment of pharyngotonsillitis due to group A beta-hemolytic streptococci: preliminary report.
    Gervaix A; Brighi L; Halpérin DS; Suter S
    J Chemother; 1995 May; 7 Suppl 1():21-4. PubMed ID: 8618109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability in the presence of widespread beta-lactamases. A prerequisite for the antibacterial activity of beta-lactam drugs.
    Schito GC; Pesce A; Debbia EA
    Drugs; 1994; 47 Suppl 3():1-8; discussion 8-9. PubMed ID: 7518761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine.
    Chosidow O; Dubruc C; Danjou P; Fuseau E; Espagne E; Bianchetti G; Thenot JP; Herson S; Rosenzweig P; Revuz J
    Eur J Clin Pharmacol; 1996; 50(4):327-33. PubMed ID: 8803528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.